Rowe JM - Search Results

1

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).

Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, Burnett AK, Chopra R, Wiernik PH, Foroni L, Paietta E, Litzow MR, Marks DI, Durrant J, McMillan A, Franklin IM, Luger S, Ciobanu N, Rowe JM. Goldstone AH, et al. Among authors: rowe jm. Blood. 2008 Feb 15;111(4):1827-33. doi: 10.1182/blood-2007-10-116582. Epub 2007 Nov 29. Blood. 2008. PMID: 18048644 Free article. Clinical Trial.

2

Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.

Dutcher JP, Eudey L, Wiernik PH, Paietta E, Bennett JM, Arlin Z, Kellermeyer R, Rowe J, O'Connell M, Oken M, et al. Dutcher JP, et al. Among authors: rowe j. Leukemia. 1992 Aug;6(8):770-5. Leukemia. 1992. PMID: 1379312 Clinical Trial.

3

Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.

Rowe JM, Andersen JW, Cassileth PA, Oken MM, Bennett JM, Wiernik PH. Rowe JM, et al. Leukemia. 1992 Nov;6 Suppl 4:75-7. Leukemia. 1992. PMID: 1434840 Clinical Trial. No abstract available.

4

Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation.

Lazarus HM, Rowe JM. Lazarus HM, et al. Among authors: rowe jm. Blood Rev. 1994 Sep;8(3):169-78. doi: 10.1016/0268-960x(94)90078-v. Blood Rev. 1994. PMID: 7529606 Review.

5

New and experimental therapies for treating graft-versus-host disease.

Lazarus HM, Rowe JM. Lazarus HM, et al. Among authors: rowe jm. Blood Rev. 1995 Jun;9(2):117-33. doi: 10.1016/s0268-960x(95)90031-4. Blood Rev. 1995. PMID: 7580389 Free article. Review. No abstract available.

6

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.

Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC, Rowe JM, Wiernik PH. Tallman MS, et al. Among authors: rowe jm. J Clin Oncol. 1995 Jul;13(7):1557-63. doi: 10.1200/JCO.1995.13.7.1557. J Clin Oncol. 1995. PMID: 7602344 Clinical Trial.

7

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH. Rowe JM, et al. Blood. 1995 Jul 15;86(2):457-62. Blood. 1995. PMID: 7605984 Free article. Clinical Trial.

8

Bone marrow transplantation for acute lymphoblastic leukemia (ALL).

Lazarus HM, Rowe JM. Lazarus HM, et al. Among authors: rowe jm. Med Oncol. 1994;11(2):75-88. doi: 10.1007/BF02988834. Med Oncol. 1994. PMID: 7850267 Review.

9

Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.

Tallman MS, Rowe JM. Tallman MS, et al. Among authors: rowe jm. Blood Rev. 1994 Jun;8(2):70-8. doi: 10.1016/s0268-960x(05)80010-4. Blood Rev. 1994. PMID: 7950477 Review. No abstract available.

10

The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.

Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH. Paietta E, et al. Leukemia. 1994 Jul;8(7):1108-12. Leukemia. 1994. PMID: 8035602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters